Survival outcomes favored the higher dose: more than 93% of patients in the 70 Gy group were alive one year after treatment, ...

For the first time in years, small cell lung cancer (SCLC) patients have reason for renewed hope as more treatment options ...

A grandad diagnosed with stage 4 lung cancer–one of the deadliest—has become disease-free after being treated with an ...

JAMA Internal Medicine published an article, Projected Lifetime Cancer Risks From Current Computed Tomography Imaging, that uses risk modeling to suggest that radiation from Computed Tomography (CT) ...

Genetic testing for hereditary cancer unexpectedly uncovers a case of myelodysplastic syndrome (MDS), highlighting the need ...

As National Cancer Survivors Month begins, survivors and medical professionals are highlighting the impact of personalized ...

One year after becoming the first centre to open a global clinical trial of a radioligand therapy for metastatic prostate ...

Lung cancer is the leading cause of cancer-related deaths in Australia. In 2024, it was the fifth most diagnosed cancer ...